SCICLONE PHARMACEUTICALS Trademark

Trademark Overview

On Thursday, June 18, 1992, a trademark application was filed for SCICLONE PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the SCICLONE PHARMACEUTICALS trademark a serial number of 74287132. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 14, 2025. This trademark is owned by SciClone Pharmaceuticals, Inc.. The SCICLONE PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical drugs used for the treatment of infectious diseases, cancer and immune system disorders
sciclone pharmaceuticals

General Information

Serial Number74287132
Word MarkSCICLONE PHARMACEUTICALS
Filing DateThursday, June 18, 1992
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 14, 2025
Registration Number1848049
Registration DateTuesday, August 2, 1994
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 12, 1993

Trademark Statements

Goods and Servicespharmaceutical drugs used for the treatment of infectious diseases, cancer and immune system disorders
NOT AVAILABLE"PHARMACEUTICALS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes018
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 14, 2025
Primary Code005
First Use Anywhere DateMonday, March 15, 1993
First Use In Commerce DateMonday, March 15, 1993

Trademark Owner History

Party NameSciClone Pharmaceuticals, Inc.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressFoster City, CA 944042125
Party NameSciClone Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Mateo, CA 94404
Party NameSciClone Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Mateo, CA 94404
Party NameSciClone Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Mateo, CA 94404

Trademark Events

Event DateEvent Description
Wednesday, September 30, 1992ASSIGNED TO EXAMINER
Friday, September 11, 1992ASSIGNED TO EXAMINER
Friday, May 6, 1994ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, October 22, 1992EXAMINER'S AMENDMENT MAILED
Monday, November 2, 1992APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 11, 1992NOTICE OF PUBLICATION
Tuesday, January 12, 1993PUBLISHED FOR OPPOSITION
Tuesday, April 6, 1993NOA MAILED - SOU REQUIRED FROM APPLICANT
Friday, September 10, 1993USE AMENDMENT FILED
Tuesday, October 26, 1993STATEMENT OF USE PROCESSING COMPLETE
Tuesday, November 23, 1993NON-FINAL ACTION MAILED
Tuesday, April 19, 1994CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 2, 1994REGISTERED-PRINCIPAL REGISTER
Wednesday, July 2, 2014TEAS SECTION 8 & 9 RECEIVED
Wednesday, July 19, 2000REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Thursday, October 19, 2000REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, July 6, 2004REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Wednesday, April 13, 2005ASSIGNED TO PARALEGAL
Wednesday, April 13, 2005REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, April 13, 2005REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, February 17, 2009TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 17, 2009APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 2, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, February 14, 2025CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Wednesday, July 8, 2015NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, July 15, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, July 8, 2015REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, July 8, 2015REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

Related Keywords

pharmaceuticals sciclone cancer immune system disorders diseases infectious drugs used treatment pharmaceutical